- Home
- RMTI vs TXMD Comparison
RMTI vs TXMD Comparison
Compare RMTI & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMTI | TXMD |
|---|---|---|
| Founded | 1994 | 2008 |
| Country | United States | United States |
| Employees | 300 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7M | 24.4M |
| IPO Year | 2022 | 2012 |
Fundamental Metrics
Financial Performance| Metric | RMTI | TXMD |
|---|---|---|
| Price | $0.66 | $2.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 316.2K | 57.9K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.68 |
| EPS | N/A | ★ 0.01 |
| Revenue | ★ $69,258,000.00 | $1,761,000.00 |
| Revenue This Year | $8.64 | N/A |
| Revenue Next Year | $8.44 | N/A |
| P/E Ratio | ★ N/A | $195.00 |
| Revenue Growth | N/A | ★ 35.25 |
| 52 Week Low | $0.60 | $0.98 |
| 52 Week High | $2.10 | $2.95 |
Technical Indicators
Market Signals| Indicator | RMTI | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 35.53 | 43.96 |
| Support Level | $0.60 | $1.90 |
| Resistance Level | $1.00 | $2.16 |
| Average True Range (ATR) | 0.04 | 0.16 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 26.60 | 24.19 |
Price Performance
Historical ComparisonAbout RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.